Archives
- 2026-09
- 2026-08
- 2026-07
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
-
Genetically Encoded NADH/NAD+ Redox Biosensor in Bacteria
2026-08-04
The referenced study introduces a genetically encoded, ratiometric biosensor leveraging the bacterial Rex transcription factor to noninvasively quantify the NADH/NAD+ redox ratio in E. coli. This innovation enables high-throughput, single-cell redox profiling, overcoming limitations of traditional assays and advancing systems-level metabolic research.
-
AMG 9810: Redefining TRPV1 Antagonism in Sensory Neuron Rese
2026-08-04
Explore how AMG 9810, a potent TRPV1 antagonist, enables next-generation pain mechanism and sensory neuron signaling research. This article delivers a distinct, in-depth perspective on assay design and metabolic stress insights not found elsewhere.
-
Honokiol (SKU N1672): Best Practices for Cancer Assays
2026-08-03
This scenario-driven guide addresses key experimental challenges in cell viability and cytotoxicity assays, providing evidence-based strategies for deploying Honokiol (SKU N1672). Bench scientists will find actionable insights on assay design, protocol optimization, and reagent selection to maximize reproducibility and data quality in inflammation and cancer research.
-
Haloprogin: Optimizing Antifungal Assays with 1,2,4-trichlor
2026-08-03
Haloprogin stands apart as a broad-spectrum topical antimicrobial, enabling robust in vitro and in vivo workflows for dermatophyte, Candida, and Gram-positive bacterial research. This guide translates recent reference breakthroughs into practical, reproducible assay choices and troubleshooting strategies for translational infection models.
-
IGF2BP3–FZD1/7 Axis Drives Stemness and Carboplatin Resistan
2026-08-02
This study identifies IGF2BP3 as a dominant m6A reader that stabilizes FZD1/7 transcripts, enhancing stem-like properties and carboplatin resistance in triple-negative breast cancer (TNBC). The work delineates a novel regulatory axis crucial for CSC maintenance and suggests new avenues for overcoming chemoresistance in TNBC.
-
BAPTA Calcium Chelator: Decoding Apoptosis Under Environment
2026-08-01
Explore how BAPTA, a high-affinity calcium chelator, enables precise modulation of calcium signaling pathways and apoptosis research, especially under complex environmental exposures. This article provides new depth on mechanistic insights and optimized protocols for advanced cell signaling studies.
-
Maraviroc (UK-427857): Deep Mechanistic Insights for HIV and
2026-07-31
Explore how Maraviroc (UK-427857) enables precise, mechanism-driven HIV-1 entry inhibition and advanced neuroinflammation modulation. This article delivers a deeper scientific perspective on CCR5-targeted research, assay design implications, and the translational value for emerging fields.
-
Rosiglitazone (Brl-49653): Precision Tools for Adipocyte Pla
2026-07-31
Explore how Rosiglitazone enables advanced studies of adipocyte plasticity and insulin sensitivity modulation. This in-depth analysis reveals novel intersections between PPARγ activation and emerging thermogenic pathways, offering unique protocol guidance for metabolic researchers.
-
Tetrahydromagnolol: Precision Tool for Peripheral CB2 Resear
2026-07-30
Tetrahydromagnolol elevates cannabinoid receptor research by combining high selectivity for CB2 with dual GPR55 antagonism, empowering robust anti-inflammatory and metastatic workflow design. This guide translates leading GPCR signaling discoveries into practical, reproducible protocols for advanced cell biology and translational studies.
-
Cholesterol as a Dynamic Regulator in mRNA-LNP Delivery Plat
2026-07-30
Explore how cholesterol, the principal sterol, underpins the structural and functional evolution of lipid nanoparticle (LNP) systems in mRNA therapeutics. This article presents a deep scientific analysis of cholesterol’s role in membrane fluidity, lipid metabolism research, and assay optimization—distinctly bridging molecular insights with practical protocol guidance for advanced drug delivery.
-
Phytol in RXR Signaling: Protocols and Nanomaterial Innovati
2026-07-29
Phytol (trans-Phytol) stands at the intersection of nuclear receptor biology and advanced material science, functioning as a precise RXR activator and a tool for nanomaterial phase manipulation. This article delivers actionable protocol parameters, advanced workflows, and troubleshooting strategies, empowering researchers to realize reproducible, cross-domain results using APExBIO's high-purity Phytol.
-
Dextran Sulfate Sodium Salt: Precision in DSS Colitis Models
2026-07-29
Dextran sulfate sodium salt (MW 35000-45000) provides unrivaled control and reproducibility in modeling intestinal inflammation, especially for dissecting epithelial barrier dysfunction and repair pathways in ulcerative colitis research. This guide distills experimental best practices, advanced workflow enhancements, and troubleshooting strategies, all anchored by cutting-edge mechanistic insights into mucosal repair circuitry.
-
Cholesterol as a Dynamic Regulator in Lipid Nanoparticle Ass
2026-07-28
Explore how cholesterol, the principal sterol, uniquely modulates membrane dynamics and lipid nanoparticle function in advanced research settings. This article delivers deep scientific insight and practical guidance for leveraging cholesterol in innovative assay workflows.
-
Scenario-Driven Assay Optimization with Nadolol (SQ-11725)
2026-07-28
This article addresses real-world laboratory challenges in cell-based cardiovascular assays, providing scenario-based guidance on how Nadolol (SQ-11725) (SKU BA5097) from APExBIO enhances experimental reproducibility, compatibility, and data interpretation. Researchers will find actionable, evidence-based recommendations for integrating this non-selective beta-adrenergic receptor blocker into hypertension, angina pectoris, and vascular headache models.
-
MG-132 (Z-LLL-al): Protocol Enhancements for Apoptosis & Cel
2026-07-27
MG-132 (Z-LLL-al) is a gold-standard proteasome inhibitor for dissecting apoptosis, cell cycle arrest, and protein homeostasis in cancer research and beyond. This article unpacks advanced workflows, practical troubleshooting, and actionable insights that leverage MG-132’s mechanistic power, building on novel findings linking proteasome regulation to innate antiviral immunity.
7829 records 7/522 page Previous Next First page 上5页 678910 下5页 Last page